What has NICE said?

Aflibercept (Eylea) injections are recommended as a possible treatment for some people with sight problems caused by diabetic macular oedema, as explained below.

What does this mean for me?

If you have diabetic macular oedema and the central retina of your eye is 400 micrometres thick or more before treatment, and your doctor thinks that aflibercept is the right treatment, you should be able to have the treatment on the NHS.

Aflibercept injections should be available on the NHS within 3 months of the guidance being issued.

If you are already having aflibercept injections for diabetic macular oedema and the central retinal thickness was less than 400 micrometres when treatment started, you should be able to continue having them until you and your doctor decide it is the right time to stop.

  • Information Standard